The global needle-free drug delivery devices market is projected to reach around US$ 31.4 billion by 2034, up from US$ 15.1 billion in 2024, growing at a CAGR of 7.6% during the forecast period from 2025 to 2034. This market is expanding steadily, driven by advancements in healthcare technology and increasing demand for safer drug delivery solutions. One of the major growth drivers is the...

The global muscle relaxant drugs market is projected to reach around US$ 7.8 billion by 2034, up from US$ 4.9 billion in 2024, growing at a CAGR of 4.8% during the forecast period. In 2024, North America led the market, capturing over 38.4% share with revenue reaching approximately US$ 1.9 billion. This growth is mainly driven by rising cases of muscle-related disorders and the growing need for...

The global Liposome Drug Delivery Market is projected to grow from USD 5.7 billion in 2024 to around USD 29.6 billion by 2034, expanding at a strong CAGR of 8.9%. This growth is driven by the increasing demand for targeted and safer drug delivery methods. Liposomes are small, fat-based vesicles that can transport drugs directly to affected tissues. This improves drug absorption and reduces...

The global Liposome Drug Delivery Market is projected to grow from USD 5.7 billion in 2024 to around USD 29.6 billion by 2034, expanding at a strong CAGR of 8.9%. This growth is driven by the increasing demand for targeted and safer drug delivery methods. Liposomes are small, fat-based vesicles that can transport drugs directly to affected tissues. This improves drug absorption and reduces...

The global Liposome Drug Delivery Market is projected to grow from USD 5.7 billion in 2024 to around USD 29.6 billion by 2034, expanding at a strong CAGR of 8.9%. This growth is driven by the increasing demand for targeted and safer drug delivery methods. Liposomes are small, fat-based vesicles that can transport drugs directly to affected tissues. This improves drug absorption and reduces...

The global Drug Eluting Balloon (DEB) Market is projected to grow from US$ 1.9 billion in 2024 to US$ 3.2 billion by 2034, at a steady CAGR of 5.4%. In 2024, North America held the largest market share at 36.7%, contributing approximately US$ 0.7 billion in revenue. This growth is closely tied to the rising burden of cardiovascular diseases (CVDs) worldwide. As per the World Health Organization...

The global dermatological drugs market is projected to grow from USD 25.6 billion in 2024 to USD 68.9 billion by 2034. This reflects a strong compound annual growth rate (CAGR) of 10.4% over the forecast period. A key factor behind this growth is the increasing number of people suffering from skin conditions. The World Health Organization (WHO) reports that over 900 million individuals are...

The global DNA repair drugs market is projected to grow from USD 8.3 billion in 2024 to USD 30.5 billion by 2034. This growth reflects a strong compound annual growth rate (CAGR) of 13.9% during the forecast period. In 2024, North America led the market with over 38.8% share, generating USD 3.2 billion in revenue. The market is expanding due to the increasing burden of cancer, rising use of...

The global leuprorelin drugs market is expected to reach US$ 5.1 billion by 2034, rising from US$ 2.9 billion in 2024. The market is projected to grow at a CAGR of 5.8% between 2025 and 2034. Leuprorelin is widely used to manage hormone-related disorders such as prostate cancer, endometriosis, uterine fibroids, early-onset puberty, and infertility. This steady rise in demand is linked to...

The global compounded topical drug market is projected to grow from US$ 4.3 billion in 2024 to US$ 6.8 billion by 2034, with a CAGR of 4.7% during the forecast period. In 2024, North America led the market with a 39.8% share, generating over US$ 1.7 billion in revenue. This growth is largely driven by the rising prevalence of chronic skin conditions such as eczema, dermatitis, and psoriasis....